MAGENTA THERAPEUTICS, INC.

Profile

Company Names

MAGENTA THERAPEUTICS, INC.

Addresses

50 HAMPSHIRE STREET, 8TH FLOOR, CAMBRIDGE, MA 02139

245 FIRST STREET, 4TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

857-242-0170
857-201-2700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$116,018,629.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-04-02 
$52,299,655.00 
$52,299,655.00 
$0.00 
Equity 
2
2017-04-21 
$46,000,000.00 
$50,000,000.00 
$4,000,000.00 
Equity 
1
2016-11-10 
$17,718,974.00 
$48,663,974.00 
$30,945,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
ALBERS 
DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  SCORPION THERAPEUTICS, INC.   |  ANTARES THERAPEUTICS, INC.
MICHAEL 
 
BONNEY 
DIRECTOR
REVOLUTION MEDICINES, INC.   |  MAGENTA THERAPEUTICS, INC.   |  GEORGETOWN BROADBAND LLC
BRUCE 
 
BOOTH 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  AVILA THERAPEUTICS INC   |  ZAFGEN, INC.   |  NIMBUS DISCOVERY, LLC   |  ON-Q-ITY, INC.   |  NUMERATE INC   |  UNUM THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  AVROBIO, INC.   |  MAGENTA THERAPEUTICS, INC.   |  ATLAS VENTURE FUND XI, L.P.   |  RODIN THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  VIGIL NEUROSCIENCE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  MATCHPOINT THERAPEUTICS INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
ALEXIS 
 
BORISY 
DIRECTOR
FOUNDATION MEDICINE, INC.   |  FORMA THERAPEUTICS HOLDINGS LLC   |  BLUEPRINT MEDICINES CORP   |  EDITAS MEDICINE, INC.   |  REVOLUTION MEDICINES, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  MAGENTA THERAPEUTICS, INC.   |  CELSIUS THERAPEUTICS, INC.   |  TANGO THERAPEUTICS, INC.   |  RELAY THERAPEUTICS, INC.   |  CURIE BIO SERIES A FUND I, L.P.   |  CURIE BIO SEED FUND II, L.P.   |  CURIE BIO SEED FUND II-A, L.P.
BLAKE 
 
BYERS 
DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  IONQ, INC.   |  SPOTLIGHT THERAPEUTICS, INC.   |  NEUTRON HOLDINGS, INC.   |  NEWLIMIT, INC.
THOMAS 
 
DANIEL 
DIRECTOR
JUNO THERAPEUTICS, INC.   |  MAGENTA THERAPEUTICS, INC.   |  IMMUSANT, INC.   |  CRITICAL TELEPHONE APPLICATIONS, INC   |  VIR BIOTECHNOLOGY, INC.
JOHN 
 
DAVIS 
EXECUTIVE OFFICER
INFORMA PLC   |  BANKVEST INC   |  VARSITY WORTH HILLS, LP   |  BLAZE PIZZA, LLC   |  OCC EQUITY MEMBERS, LLC   |  TMG HOLDINGS, LLC   |  TEAM LEADS MANAGEMENT, LLC   |  MIAMI INTERNATIONAL HOLDINGS, INC.   |  SPRING BANCORP INC   |  MAGENTA THERAPEUTICS, INC.   |  SHIFT GROUP HOLDINGS, INC.   |  PAG BRS III FEEDER FUND L.P.   |  PAG BRS FUND III L.P.   |  SOLIDION TECHNOLOGY INC.
JASON 
 
GARDNER 
EXECUTIVE OFFICER, DIRECTOR
WEBVISIBLE INC   |  MARQETA, INC.   |  KAREO INC   |  MAGENTA THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  PATIENTPOP, INC.
AMY 
 
RONNEBERG 
DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  ACTUATE THERAPEUTICS, INC.
BASTIANO 
 
SANNA 
EXECUTIVE OFFICER
MAGENTA THERAPEUTICS, INC.   |  SEMMA THERAPEUTICS, INC.
DAVID 
 
SCADDEN 
DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  CLEAR CREEK BIO, INC.   |  LIFEVAULT BIO, INC.   |  PHOENIX ENERGY ONE, LLC   |  ADAMANTIUM CAPITAL LLC
ZORAN 
 
ZDRAVESKI 
EXECUTIVE OFFICER
MAGENTA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-04-02 
2017-05-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-21 
2016-11-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#